IJCRR - 6(12), June, 2014
EFFECT OF BODY MASS INDEX ON FOLLICLE STIMULATING HORMONE, LUTEINIZING HORMONE, PROLACTIN AND FASTING BLOOD GLUCOSE LEVELS IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME
Author: V. Rajitha, G. Rekha, K.Y.Manjunath
Background: Obesity is a modern day scourge which plays havoc on the menstrual life of women in the reproductive age group. Disorders of menstrual cycle affect the women psychologically as well as physically. To estimate the obesity of an individual a cost effective method is to calculate the BMI (Body Mass Index). This is a reliable tool in early detection of Obesity and its associated disorders. In women of the reproductive age group an increased Body Mass Index results in alteration of hormonal levels resulting in altered menstrual cycles. In women with polycystic ovarian syndrome, the hormonal levels are so altered that many cycles are anovulatory. Estimation of Body Mass Index and comparing them with the hormonal levels will provide a fair idea in understanding the disease process. Materials and Methods: The test subjects were 79 apparently healthy women volunteers. They were divided into two groups based on menstrual history. Nineteen subjects were in control group and sixty were in the test group. BMI was calculated for both the groups. Blood levels of FSH, LH and Fasting Blood Glucose was estimated after obtaining consent and withdrawal of blood was done under aseptic precautions. The resultant measurements were subjected to statistical analysis, Results: The mean BMI of the test group was 25.48 Kg/m2and the mean BMI of the control group was 23.07Kg/m2. The Mean FSH levels in test group 7.88 mIU/ml and in the control group it was 8.95mIU/ml. The mean Prolactin levels in the test group were 16.635 ng/ml and in the control group it was 10.35 ng/ml. The mean LH levels in the test group were 6.53mIU/ml and in the control group it was 3.76mIU/ml. The mean fasting blood glucose levels in the test group was 94 mg/dl and in the control group it was 84 mg/dl. Conclusion: It is evident from the present study that the mean hormonal levels of LH and Prolactin and the fasting blood glucose levels are significantly higher in persons with polycystic ovarian syndrome and the FSH levels are lower in persons with polycystic ovarian syndrome which indicates that there could be always increased number of anovulatory cycles in such individuals.
Keywords: Body mass index, Follicle stimulating hormone, Luteinizing hormone, Prolactin, Glucose, polycystic ovarian syndrome.
V. Rajitha, G. Rekha, K.Y.Manjunath. EFFECT OF BODY MASS INDEX ON FOLLICLE STIMULATING HORMONE, LUTEINIZING HORMONE, PROLACTIN AND FASTING BLOOD GLUCOSE LEVELS IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME International Journal of Current Research and Review. 6(12), June, 49-55
1. Dunaif A. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774– 800.
2. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29:181.
3. Zawadski JK, Dunaif A Diagnostic criteria for Polycystic ovary syndrome: Towards a rational approach. In: Dunaif A, Givens JR, HaseltineF(Eds). Polycystic ovary syndrome. Boston: Blackwell Scientific 1992;377.84
4. Ferdousi Begum., Clinical and Hormonal profile of Polycystic ovary syndrome. South Asian Federation of Obstetrics and Gynecology, May- August 2009;1(2):22-25
5. XiaoliChen,Renmin Ni, Yaqin Mo, Lin Li and Dongzi Yang. Appropriate BMI levels for PCOS patients in Southern China.Human Reproduction, Vol.25,No.5 pp 1295- 1302,2010
6. Dale PO, Tanbo T, Vaaler S, Abyholm T. Body weight ,hyperinsulinemia and gonadotropin levels in the Polycystic ovarian syndrome: evidence in two population Fertility and Sterility. 1992,58(38):487-491
7. McKeigue PM, Shah B, Marmot MG.Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet .1991;337:382-6.
8. The World Health Organization Western Pacific Region, the International Association for the Study of Obesity, and the International Obesity TaskForce. The Asia–Pacific Perspective: Redefining Obesity and its Treatment. Melbourne: Health Communications Australia, 2000.
9. Misra A, Chowbey P, Makkar BM, Vikram NK, Chadha D, et al. Consesus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009;57:163-70
10. The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus WorkshopGroup. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19:41–47.
11. SunitaJ.Ramanand, Balasaheb B Ghongane, et al. Clinical characteristics of polycystic ovary syndrome in Indian women. Indian J EndocrinolMetab. 2013 Jan-Feb: 17(1): 138- 145.
12. Bulent O. Yildiz, Eric S. Knochenhauer, et al. Impact of Obesity on the Risk for Polycystic Ovary Syndrome. J ClinEndocrinolMetab. Jan 2008; 93(1): 162-168.
13. Barber TM, McCarthy MI, Wass JA, Franks S 2006; Obesity and polycystic ovary syndrome. ClinEndocrinol (Oxf) 65:137-145. [PubMed].
14. Pagan YL, Srouji SS, Jimenez Y, et al. Inverse relationship between luteinizing hormone and body mass index in polycystic ovarian syndrome: investigation of hypothalamic and pituitary contributions. J ClinEndocrinolMetab 2006 Apr; 91(4):1309- 16.
15. Jan Holte, Torbjorn Bergh, et al. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopauseal women. Clinical Endocrinology Volume 41, Issue 4, 1994: 473-481.